EVMN R&D Expenses
Evommune, Inc. Common Stock · R&D Expenses
EVMN R&D Expenses
Latest reported$83.77Mperiod ending
EVMN TTM R&D Expenses ($61.97M → $83.77M)
TTM R&D Expenses
High-resolution chart · PNG
EVMN r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 83,773,000 | |
| 76,999,000 | |
| 74,042,000 | |
| 69,198,500 | |
| 62,848,500 | |
| 68,388,500 | |
| 61,973,500 |